295 related articles for article (PubMed ID: 27622023)
1. Embracing rejection: Immunologic trends in brain metastasis.
Farber SH; Tsvankin V; Narloch JL; Kim GJ; Salama AK; Vlahovic G; Blackwell KL; Kirkpatrick JP; Fecci PE
Oncoimmunology; 2016 Jul; 5(7):e1172153. PubMed ID: 27622023
[TBL] [Abstract][Full Text] [Related]
2. Suppressing immunotherapy by organ-specific tumor microenvironments: what is in the brain?
Zhang C; Yu D
Cell Biosci; 2019; 9():82. PubMed ID: 31624532
[TBL] [Abstract][Full Text] [Related]
3. Cerebral metastasis during remission after immunotherapy for metastatic urothelial carcinoma: A case report.
Iwata S; Niimi F; Danno T; Honda S; Azuma T
Mol Clin Oncol; 2021 Jul; 15(1):145. PubMed ID: 34094543
[TBL] [Abstract][Full Text] [Related]
4. The blood-brain barrier and its role in immune privilege in the central nervous system.
Pachter JS; de Vries HE; Fabry Z
J Neuropathol Exp Neurol; 2003 Jun; 62(6):593-604. PubMed ID: 12834104
[TBL] [Abstract][Full Text] [Related]
5. The role of the immune system in brain metastasis.
Leibold AT; Monaco GN; Dey M
Curr Neurobiol; 2019 Jul; 10(2):33-48. PubMed ID: 31097897
[TBL] [Abstract][Full Text] [Related]
6. Microenvironmental Regulation of Tumor Progression and Therapeutic Response in Brain Metastasis.
Schulz M; Salamero-Boix A; Niesel K; Alekseeva T; Sevenich L
Front Immunol; 2019; 10():1713. PubMed ID: 31396225
[TBL] [Abstract][Full Text] [Related]
7. Immune Microenvironment of Brain Metastases-Are Microglia and Other Brain Macrophages Little Helpers?
You H; Baluszek S; Kaminska B
Front Immunol; 2019; 10():1941. PubMed ID: 31481958
[TBL] [Abstract][Full Text] [Related]
8. The microenvironment of brain metastases from solid tumors.
Srinivasan ES; Deshpande K; Neman J; Winkler F; Khasraw M
Neurooncol Adv; 2021 Nov; 3(Suppl 5):v121-v132. PubMed ID: 34859239
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy in NSCLC patients with brain metastases. Understanding brain tumor microenvironment and dissecting outcomes from immune checkpoint blockade in the clinic.
Vilariño N; Bruna J; Bosch-Barrera J; Valiente M; Nadal E
Cancer Treat Rev; 2020 Sep; 89():102067. PubMed ID: 32682248
[TBL] [Abstract][Full Text] [Related]
10. Treatment of brain metastases in the modern genomic era.
Dagogo-Jack I; Gill CM; Cahill DP; Santagata S; Brastianos PK
Pharmacol Ther; 2017 Feb; 170():64-72. PubMed ID: 27773784
[TBL] [Abstract][Full Text] [Related]
11. Melanoma Brain Metastases: Current Areas of Investigation and Future Directions.
Glitza Oliva I; Tawbi H; Davies MA
Cancer J; 2017; 23(1):68-74. PubMed ID: 28114258
[TBL] [Abstract][Full Text] [Related]
12. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review.
Lossinsky AS; Shivers RR
Histol Histopathol; 2004 Apr; 19(2):535-64. PubMed ID: 15024715
[TBL] [Abstract][Full Text] [Related]
13. Molecular determinants of lung cancer metastasis to the central nervous system.
Whitsett TG; Inge LJ; Dhruv HD; Cheung PY; Weiss GJ; Bremner RM; Winkles JA; Tran NL
Transl Lung Cancer Res; 2013 Aug; 2(4):273-83. PubMed ID: 25806243
[TBL] [Abstract][Full Text] [Related]
14. Control of the blood-brain barrier function in cancer cell metastasis.
Blecharz KG; Colla R; Rohde V; Vajkoczy P
Biol Cell; 2015 Oct; 107(10):342-71. PubMed ID: 26032862
[TBL] [Abstract][Full Text] [Related]
15. Does VEGF secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight-junction proteins in central nervous system leukemia?
Feng S; Huang Y; Chen Z
Med Hypotheses; 2011 May; 76(5):618-21. PubMed ID: 21398042
[TBL] [Abstract][Full Text] [Related]
16. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Central Nervous System Metastases from Non-Small Cell Lung Cancer.
Ahluwalia MS; Becker K; Levy BP
Oncologist; 2018 Oct; 23(10):1199-1209. PubMed ID: 29650684
[TBL] [Abstract][Full Text] [Related]
17. Neural immune modulation and immunotherapy assisted by focused ultrasound induced blood-brain barrier opening.
Chen PY; Wei KC; Liu HL
Hum Vaccin Immunother; 2015; 11(11):2682-7. PubMed ID: 26378609
[TBL] [Abstract][Full Text] [Related]
18. Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo.
Tietz SM; Engelhardt B
J Vis Exp; 2019 Mar; (145):. PubMed ID: 30985749
[TBL] [Abstract][Full Text] [Related]
19. Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology.
Meng J; Agrahari V; Youm I
J Neuroimmune Pharmacol; 2017 Mar; 12(1):84-98. PubMed ID: 27449494
[TBL] [Abstract][Full Text] [Related]
20. Blood-Brain Barrier- and Blood-Brain Tumor Barrier-Penetrating Peptide-Derived Targeted Therapeutics for Glioma and Malignant Tumor Brain Metastases.
Chen L; Zeng D; Xu N; Li C; Zhang W; Zhu X; Gao Y; Chen PR; Lin J
ACS Appl Mater Interfaces; 2019 Nov; 11(45):41889-41897. PubMed ID: 31615203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
